{
  "docId": "019de074-2e24-777e-87b3-831358a7e33a",
  "docSlug": "971513439f6499291689438a6a6dd75f",
  "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 20 slides",
  "authorId": "compass-therapeutics",
  "authorName": "Compass Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 20,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 15,
  "notes": "The table highlights Partial Response (PR) rates with a red border, emphasizing clinical activity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2e24-777e-87b3-831358a7e33a/14",
  "deckHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a",
  "deckJsonHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a.json",
  "deckAnchorHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.035,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Clinical activity at RP2D dosages (10 and 12.5 mg/kg)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f88cfa4-c383-4776-aaf8-029cc73105d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.93,
        "x": 0.035,
        "y": 0.295
      },
      "kind": "table",
      "text": "Table showing clinical outcomes (Prior VEGF, PR, SD, Clinical Benefit Rate, TTP) for All, Colorectal, and Gastric cancer patient cohorts.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc0f5351-ddc1-4cee-98e5-fafa64c6ef5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.035,
        "y": 0.08
      },
      "kind": "title",
      "text": "Phase 1a CTX-009 Monotherapy Data",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ca920d3-4c47-4005-9d7b-3d2c6240b754",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "6f9c7e1d-2b85-4487-988c-ddf08e3845ef",
      "evidence": "table/data: Table showing clinical outcomes (Prior VEGF, PR, SD, Clinical Benefit Rate, TTP) for All, Colorectal, and Gastric cancer patient cohorts.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 13,
      "beatId": "b3085f9b-570a-424e-be88-6d33549283d5",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Market Size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "Slides 13 and 16 discuss market sizing and patient demographics, indicating the market size.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}